Bitar M, Weiner M
Diabetes. 1984 Jan;33(1):37-44. doi: 10.2337/diab.33.1.37.
Diabetes-induced alterations in heme and hemoproteins, as well as its relationship to drug-mediated induction of ALA Synthase (ALA-S), were examined in female Sprague-Dawley rats. Animals were rendered diabetic by a single i.v. injection of streptozotocin (STZ, 65 mg/kg) and measurements were made at various times after treatment. The basal levels of the key enzymes involved in heme synthesis, ALA-S and ALA-dehydratase (ALA-D), were decreased about 36% and 54%, respectively, 44-46 days after diabetes induction. Furthermore, the catabolism of heme that occurs via microsomal heme oxygenase progressively decreases in activity during the course of diabetes, and reaches 69% of control in 90-day diabetic animals. The basal levels of heme, cytochromes P-450 and b5 were elevated about twofold in diabetic rats as compared with their corresponding control values. The activity of benzo(a)pyrene hydroxylase in diabetic rats was also increased in proportion to the microsomal content of cytochrome P-450. In contrast, delta 4-hydrogenase, the rate-limiting enzyme in corticosterone metabolism, exhibited a 35-65% decrease in activity throughout the experimental period. Tryptophan pyrrolase activity (total, holo-, and apoenzyme) was elevated about 2.5-fold in STZ diabetic rats. In vivo insulin therapy of diabetic animals antagonized the effect of the diabetic state on the above measured parameters. Treatment with aminoglutethimide resulted in about a twofold elevation in ALA-S activity in control as well as chronically diabetic rats. However, a similar stimulatory response in ALA-S activity to CoCl2 administration was observed only in control or insulin-treated diabetic rats.(ABSTRACT TRUNCATED AT 250 WORDS)
在雌性斯普拉格-道利大鼠中研究了糖尿病引起的血红素和血红蛋白改变,以及其与药物介导的δ-氨基-γ-酮戊酸合酶(ALA-S)诱导的关系。通过单次静脉注射链脲佐菌素(STZ,65mg/kg)使动物患糖尿病,并在治疗后的不同时间进行测量。糖尿病诱导后44-46天,血红素合成中关键酶δ-氨基-γ-酮戊酸合酶(ALA-S)和δ-氨基-γ-酮戊酸脱水酶(ALA-D)的基础水平分别降低了约36%和54%。此外,在糖尿病病程中,通过微粒体血红素加氧酶发生的血红素分解代谢活性逐渐降低,在90天糖尿病动物中降至对照的69%。与相应对照值相比,糖尿病大鼠中血红素、细胞色素P-450和b5的基础水平升高了约两倍。糖尿病大鼠中苯并(a)芘羟化酶的活性也与细胞色素P-450的微粒体含量成比例增加。相反,皮质酮代谢中的限速酶δ4-脱氢酶在整个实验期间活性降低了35%-65%。色氨酸吡咯酶活性(总酶、全酶和脱辅基酶)在STZ糖尿病大鼠中升高了约2.5倍。对糖尿病动物进行体内胰岛素治疗可拮抗糖尿病状态对上述测量参数的影响。用氨鲁米特治疗可使对照大鼠以及慢性糖尿病大鼠的ALA-S活性升高约两倍。然而,仅在对照或胰岛素治疗的糖尿病大鼠中观察到对氯化钴给药的ALA-S活性有类似的刺激反应。(摘要截断于250字)